Differences in the expression of TLRs and inflammatory cytokines in pre-eclamptic compared with healthy pregnant women

Iranian Journal of Immunology

Volumn 11, Issue 4, 2014, Pages 223-245

  Dabagh Gorjani, Feryal ^a   Anvari, Fahimeh ^a   Zolghadri, Jaleh ^a,b   Kamali Sarvestani, Eskandar ^a,c,d   Gharesi Fard, Behrouz ^a,b,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytokine; Preeclampsia; Pregnancy; Real time PCR; TLR

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR ALPHA; AUTACOID;

ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS BLOOD; GENETIC ANALYSIS; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MATERNAL BLOOD; PLACENTA; PREECLAMPSIA; PREGNANCY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; THIRD TRIMESTER PREGNANCY;

CASE-CONTROL STUDIES; CYTOKINES; FEMALE; FETAL BLOOD; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, THIRD; TOLL-LIKE RECEPTORS;

EID: 84940436514     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Grill S, Rusterholz C, Zanetti-Dällenbach R, Tercanli S, Holzgreve W, Hahn S, et al. Potential markers of preeclampsia - a review. Reprod Biol Endocrinol. 2009; 7:70.
2. Aali BS, Ghafoorian J, Mohamad-Alizadeh S. Severe pre-eclampsia and eclampsia in Kerman, Iran: complications and outcomes. Med Sci Monit. 2004; 10:163-7.
3. Group on High Blood Pressure in Pregnancy Steegers EA, von Dadelszen P, Duvekot JJ et al. Preeclampsia. Lancet. 2010; 376:631-44.
4. No authors listed. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000; 183:S1-S22.
5. Maria L, Rugolo SDS, Bentlin MR, et al. Pre‑eclampsia: Effect on the Fetus and Newborn. Neo Reviews 2011; 12:198-206.
6. Redman CW, Sargent IL. Placental Stress and Pre-eclampsia: A Revised View. Placenta. 2009; 30:S38-S42.
7. Loke YW, King A. Immunological aspects of human implantation. J Reprod Fertil Suppl. 2000; 55:83-90.
8. Guleria I, Pollard JW. The trophoblast is a component of the innate immune system during pregnancy. Nat Med. 2000; 6:589-93.
9. Van Mourik MS, Macklon NS, Heijnen CJ. Embryonic implantation: cytokines, adhesion molecules, and immune cells in establishing an implantation environment. J Leukoc Biol. 2009; 85:4-19.
10. Medzhitov R, Janeway CA Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 1997; 91:295-8.
11. Koga K, Mor G. Toll-Like Receptors at the Maternal–Fetal Interface in Normal Pregnancy and Pregnancy Disorders. Am J Reprod Immunol. 2010; 63:587-600.
12. Rindsjo E, Holmlund U, Sverremark-Ekstrom E, Papadogiannakis N, Scheynius A. Toll-like receptor-2 expression in normal and pathologic human placenta. Hum Pathol. 2007; 38:468-73.
13. Mitsunari M, Yoshida S, Shoji T, Tsukihara S, Iwabe T, Harada T, Terakawa N: Macrophageactivating lipopeptide-2 induces cyclooxygenase-2 and prostaglandin E(2) via toll-like receptor 2 in human placental trophoblast cells. J ReprodImmunol. 2006; 72:46-59.
14. Abrahams VM, Bole-Aldo P, Kim YM, Straszewski- Chavez SL, Chaiworapongsa T, Romero R, et al. Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol. 2004; 173:4286-96.
15. Cindrova-Davies T, Yung HW, Johns J, Spasic-Boskovic O, Korolchuk S, Jauniaux E, et al. Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. Am J Pathol. 2007; 171:1168-79.
16. Fest S, Aldo PB, Abrahams VM, Visintin I, Alvero A, Chen R, et al: Trophoblast-macrophage interactions: A regulatory network for the protection of pregnancy. American Journal of Reproductive Immunology. 2007; 57:55-66.
17. Ma Y, Mor G, Abrahams VM, Buhimschi IA, Buhimschi CS, Guller S: Alterations in syncytiotrophoblast cytokine expression following treatment with lipopolysaccharide. Am J ReprodImmunol. 2006; 55:12-8.
18. Dulay AT, Buhimschi CS, Zhao G, Oliver EA, Mbele A, Jing S, Buhimschi IA: Soluble TLR2 is present in human amniotic fluid and modulates the intraamniotic inflammatory response to infection. J Immunol. 2009; 182:7244-53.
19. Abrahams VM, Schaefer TM, Fahey JV et al: Expression and secretion of antiviral factors by trophoblast cells following stimulation by the TLR-3 agonist, poly (I: C). Hum Reprod. 2006; 21:2432-39.
20. Abrahams VM, Visintin I, Aldo PB, Guller S, Romero R, Mor G: A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells. J Immunol 2005; 175:8096-104.
21. Holmlund U, Cebers G, Dahlfors AR et al: Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta. Immunology.2002; 107:145-51.
22. Costello MJ, Joyce SK, Abrahams VM. NOD protein expression and function in first trimester trophoblast cells. Am J ReprodImmunol. 2007; 57:67-80.
23. Shimoya K, Moriyama A, Matsuzaki N et al: Human placental cells show enhanced production of interleukin (IL)-8 in response to lipopolysaccharide (LPS), IL-1 and tumour necrosis factor (TNF)- alpha, but not to IL-6. Mol Hum Reprod. 1999; 5:885.
24. Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia.Molecular Aspects of Medicine. 2007; 28:192-209.
25. Koga K, Aldo PB, Mor G: Toll-like receptors and pregnancy: trophoblast as modulators of the immune response. J ObstetGynaecol Res. 2009; 35:191-202.
26. Saito S, Umekage H, Sakamoto Y et al. Increased T-helper-1-type immunity and decreased Thelper- 2-type immunity in patients with pre-eclampsia. Am J ReprodImmunol.1999; 41:297-306.
27. Patni S, Wynen LP, Seager AL, Morgan G, White JO, Thornton CA: Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term. BiolReprod. 2009; 80:243-8.
28. Zhao X, Sun X, Gao F, Luo J, Sun Z: Effects of ulinastatin and docataxel on breast tumor growth and expression of IL-6, IL-8, and TNF-alpha. J ExpClin Cancer Res. 2011; 30:22.
29. Jasper MJ, Tremellen KP, Robertson SA: Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol Hum Reprod. 2006; 12:301-08.
30. Listvanova S, Temmerman S, Stordeur P, Verscheure V, Place S, et al: Optimal kinetics for quantification of antigen-induced cytokines in human peripheral blood mononuclear cells by realtime PCR and by ELISA. J Immunol Methods. 2003; 281: 27-35.
31. Vanderlelie J, Gude N, Perkins AV. Antioxidant Gene Expression in Preeclamptic Placentae: A Preliminary Investigation. Placenta. 2008; 29:519-22.
32. Pineda, A., Verdin-Teran, S. L., Camacho, A. and Moreno-Fierros, L: Expression of toll-like receptor TLR-2, TLR-3, TLR-4 and TLR-9 is increased in placentas from patients with preeclampsia. Arch Med Res. 2011; 42, 382-91.
33. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol. 2002; 186:158-66.
34. Akira S, Hoshino K. Myeloid differentiation factor 88-dependent and-independent pathways in toll-like receptor signaling. J Infect Dis. 2003; 187(suppl 2):S356-S363.
35. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell 2002; 111:927-30.
36. Aderem A, Ulevitch RJ: Toll-like receptors in the induction of the innate immune response. Nature. 2000; 406:782-7.
37. Borzychowski AM, Sargent IL, Redman CWG: Inflammation and pre-eclampsia. Semin Fetal Neonat M. 2006; 11: 309-16.
38. Sargent IL, Borzychowski AM, Redman CW: NK cells and human pregnancy–an inflammatory view. Trends Immunol. 2006; 27:399-404.
39. Bowen JM, Chamley L, Mitchell MD, and Keelan JA. Cytokines of the placenta and extraplacental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta. 2002; 23: 239-56.
40. Sheedy FJ, Moore KJ. IL-1 signaling in atherosclerosis: sibling rivalry. Nat Immunol. 2013; 14:1030-2.
41. Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB, et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol. 2013; 14:812-20.
42. Rothfuchs AG, Trumstedt C, Wigzell H, Rottenberg ME. Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on toll-like receptor 4-myeloid differentiation factor 88-IFN-alphabeta-STAT1 signaling. J Immunol.2004; 172: 6345-53.
43. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JN Jr, Bennett WA. Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol. 1999; 181: 915-20.
44. Bai X, Williams JL, Greenwood SL, Baker PN, Aplin JD, Crocker IP. A placental protective role for trophoblast-derived TNF-related apoptosis-inducing ligand (TRAIL).Placenta. 2009; 30:855-60.